Skip to main content
. 2017 Oct 27;8(62):105262–105275. doi: 10.18632/oncotarget.22166

Figure 1. RDH10 is over-expressed in human gliomas and predicts a high grade and poor prognosis.

Figure 1

(A) Characteristic micrographs of RDH10 immunostaining in gliomas at WHO grade I, II, III, and IV (magnification left, ×100 and right, ×200). (B) Analysis of RDH10 expression from GE-mini(TCGA and GTEx datasets) revealed significant differences between normal brain tissues and glioma. (C) Analysis of RDH10 expression in LGG and GBM. A generalized linear model (GLM) analysis was performed for TCGA RNA-sequencing data of Gliomas. **P < 0.01. (D) Survival analysis showed that higher RDH10 expressing gliomas had a poorer prognosis than lower RDH10 expressing gliomas. **P < 0.01.